首页> 外文期刊>Journal of Medical Virology >Lack of clinical evidence for involvement of hepatitis C virus interferon-alpha sensitivity-determining region variability in RNA-dependent protein kinase-mediated cellular antiviral responses.
【24h】

Lack of clinical evidence for involvement of hepatitis C virus interferon-alpha sensitivity-determining region variability in RNA-dependent protein kinase-mediated cellular antiviral responses.

机译:缺乏丙型肝炎病毒干扰素-α敏感性确定区域变异参与RNA依赖性蛋白激酶介导的细胞抗病毒反应的临床证据。

获取原文
获取原文并翻译 | 示例
           

摘要

The hepatitis C virus (HCV) interferon-alpha (IFN-alpha) sensitivity-determining region (ISDR) has been shown to suppress double-stranded RNA-dependent protein kinase (PKR) activity in vitro in a yeast PKR expression system. Since variability of ISDR was shown to correlate with nonresponsiveness to IFN-alpha therapy in chronically HCV-infected patients, it has been suggested that prototype ISDR might be a viral inhibitor of cellular PKR. The present study evaluates the biological significance of ISDR variability in situ, relating it to PKR-mediated cellular antiviral responses within the liver. ISDR variability was determined in patients chronically infected with HCV genotypes 1a, 1b, and 3a by direct sequencing using liver-derived RNA preparations as starting material. As surrogate parameters for PKR-mediated cellular responses, hepatic endogenous IFN-alpha gene expression as well as MxA expression were analysed by a competitive, quantitative reverse transcription-polymerase chain reaction technique. Irrespectively of intra- or intergenotypic ISDR amino acid substitutions, ISDR variability was found not to correlate with endogenous hepatic IFN-alpha or with hepatic MxA gene expression. The data suggest that at least two prominent PKR-mediated cellular responses might be largely unaffected by HCV ISDR variability. Copyright 2000 Wiley-Liss, Inc.
机译:丙型肝炎病毒(HCV)干扰素-α(IFN-α)敏感性测定区(ISDR)已显示出在酵母PKR表达系统中可抑制双链RNA依赖性蛋白激酶(PKR)活性。由于在慢性HCV感染的患者中,ISDR的变异性与对IFN-α治疗的无反应性相关,因此,有人提出,ISDR原型可能是细胞PKR的病毒抑制剂。本研究评估了原位ISDR变异的生物学意义,并将其与肝脏中PKR介导的细胞抗病毒反应相关。慢性感染HCV基因型1a,1b和3a的患者中,ISDR变异性是通过使用肝脏衍生的RNA制剂作为起始材料进行直接测序来确定的。作为PKR介导的细胞反应的替代参数,通过竞争性定量逆转录聚合酶链反应技术分析了肝内源性IFN-α基因表达以及MxA表达。无论是在基因型内还是基因型间的ISDR氨基酸取代,都发现ISDR变异性与内源性肝IFN-α或肝MxA基因表达无关。数据表明,至少两种突出的PKR介导的细胞反应可能在很大程度上不受HCV ISDR变异性的影响。版权所有2000 Wiley-Liss,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号